Foam Sclerotherapy for Fibrovein now approved in Europe.

STD Pharmaceutical has now obtained Marketing Authorization for Fibrovein Foam through the Ministries of Health of the United Kingdom, France, Spain, Portugal and the Czech Republic.  The specified approval was for Sodium Tetradecyl Sulphate (Fibrovein) concentrations of 3% and 1% with air:liquid ratios of 3:1 and 4:1.